The Future of ART Regimens for HIV Is in Long-Acting Agents

(MedPage Today) — Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don’t require a daily oral pill and two-drug regimens that could decrease toxicity associated with standard triple-drug regimens.
The…

Source link : https://www.medpagetoday.com/spotlight/hiv/116814

Author :

Publish date : 2025-08-04 17:18:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

The Future of ART Regimens for HIV Is in Long-Acting Agents

This Monkey Sanctuary Helps U.S. Veterans With PTSD Find Peace

More Colorectal Cancers Detected in Younger Adults After Guideline Change

Related Posts

Study Supports Earlier Start for Geographic Atrophy Drug

Asteroid exploded ‘similar to a bomb’ over France in a rare event

Lung Cancer Detected in 1.3% of Asian Women Nonsmokers

NICE Recommends Durvalumab for Lung Cancer Patients

LDL-Lowering Does Not Prevent CABG Graft Failure

Higher VTE Risk in Patients With IBD After First CRC Surgery

Study Supports Earlier Start for Geographic Atrophy Drug

Asteroid exploded ‘similar to a bomb’ over France in a rare event

Lung Cancer Detected in 1.3% of Asian Women Nonsmokers

NICE Recommends Durvalumab for Lung Cancer Patients

LDL-Lowering Does Not Prevent CABG Graft Failure

Higher VTE Risk in Patients With IBD After First CRC Surgery

Why Genitourinary Syndrome of Menopause Is Often Missed

Mediterranean Diet Linked to Better Periodontal Health

Categories

Archives